Children in Belo Horizonte neighborhoods where Wolbachia‑infected mosquitoes were released saw a 69 percent drop in dengue and chikungunya infections compared with similar areas that received only standard insecticide control, researchers reported Saturday at the American Society of Tropical Medicine and Hygiene meeting.
Study design tested the strategy alongside routine spraying
The four-year trial enrolled more than 5,700 schoolchildren in Belo Horizonte, a historic dengue hot spot. All neighborhoods continued to receive the same pesticide applications and other municipal mosquito‑control measures, but half were randomly assigned to receive releases of Aedes aegypti mosquitoes carrying the bacterium Wolbachia, the Associated Press reported.
Researchers collected blood samples to detect antibodies against dengue, chikungunya and Zika viruses, capturing infections that routine surveillance misses because many cases are mild or asymptomatic. The randomized, controlled design distinguishes this study from earlier observational field trials, Dr. Sri Edupuganti of Emory University, a member of the international research team, told the AP.

Protection held during Brazil’s record 2024 outbreak
The reduction in dengue and chikungunya infections persisted even during Brazil’s severe 2024 dengue surge, which saw more than six million probable cases nationwide, the AP reported. There were too few Zika infections in the study population to assess an effect on that virus.
How Wolbachia spreads through the local mosquito population
Scientists breed mosquitoes to carry Wolbachia, a bacterium common in many insects but absent from wild Aedes aegypti. The bacteria dramatically reduce the mosquitoes’ ability to transmit dengue, chikungunya and Zika viruses. Infected females pass the bacterium to their offspring, so releasing enough males and females allows Wolbachia to become established in the local mosquito population over time, according to the nonprofit World Mosquito Program, which pioneered the approach.

Independent expert sees potential for wider impact
“This is really exciting,” said Dr. David Hamer, a global‑health specialist at Boston University who was not involved in the Brazilian trial. He predicted that pairing Wolbachia releases with existing control measures could “knock dengue down to much lower levels” in many settings, he told the AP.
Florida outbreak adds urgency for U.S. consideration
The findings arrive as Florida contends with an unusually large dengue outbreak — more than 650 locally acquired cases reported as of Friday, about three‑quarters of them in Hillsborough County, home to Tampa, the AP reported. That total appears to be the highest in any U.S. state since at least the 1940s. In the continental United States, dengue is typically seen in travelers returning from endemic areas.
With a population of around 2.4 million, it is the country’s sixth-largest city and anchors the third-largest metropolitan area, home to 6 million people. The city was constructed on a grid inspired by Washington, D.C., and inaugurated in 1897 under the name Cidade de Minas before being renamed Belo Horizonte, or “Beautiful Horizon,” in 1906.
Previous trials in Indonesia showed similar promise
Earlier field studies in Indonesia demonstrated that Wolbachia deployments could significantly lower dengue diagnoses. The Belo Horizonte trial extends that evidence by using laboratory‑confirmed infection rates in children rather than relying on clinical diagnoses alone, the AP noted.
Worth a look